The Kintetsu deal is the third corporate carve-out for Blackstone, which last year invested a record $7.3 billion in Japan, including the purchase of Takeda’s over-the-counter drugs business. As …
( read original story …)
The Japan News
The Kintetsu deal is the third corporate carve-out for Blackstone, which last year invested a record $7.3 billion in Japan, including the purchase of Takeda’s over-the-counter drugs business. As …
( read original story …)